Sunshine Biopharma Inc. Deferred Tax Liabilities, Net
Sunshine Biopharma Inc. (SBFM) had Deferred Tax Liabilities, Net of $0 as of 2025-12-31, per its 10-K filed 2026-04-03.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net
us-gaap:DeferredTaxLiabilities · last filed 2026-04-03
- 2025-12-31: Deferred Tax Liabilities, Net $0.00.
- 2024-12-31: Deferred Tax Liabilities, Net $389.51K.
- 2023-12-31: Deferred Tax Liabilities, Net $225.49K; Deferred Tax Liabilities, Net as first filed $225.49K.
- 2022-12-31: Deferred Tax Liabilities, Net $344.32K.
| Period end | Deferred Tax Liabilities, Net | Deferred Tax Liabilities, Net as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-04-03 | |
| 2024-12-31 | $389.51K 10-K · filed 2026-04-03 | |
| 2023-12-31 | $225.49K 10-K · filed 2025-04-01 | $225.49K 10-K · filed 2024-03-28 |
| 2022-12-31 | $344.32K 10-K · filed 2023-04-04 | |
| 2015-12-31 | $0.00 10-K · filed 2016-03-25 | |
| 2014-12-31 | $0.00 10-K · filed 2016-03-25 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |